<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37342998</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3375</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PLOS global public health</Title><ISOAbbreviation>PLOS Glob Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence of long COVID decreases for increasing COVID-19 vaccine uptake.</ArticleTitle><Pagination><StartPage>e0001917</StartPage><MedlinePgn>e0001917</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0001917</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgph.0001917</ELocationID><Abstract><AbstractText>Long COVID is a post-COVID-19 condition characterized by persistent symptoms that can develop after SARS-CoV-2 infection. Estimating and comparing its prevalence across countries is difficult, hindering the quantitative assessment of massive vaccination campaigns as a preventive measure. By integrating epidemiological, demographic and vaccination data, we first reconcile the estimates of long COVID prevalence in the U.K. and the U.S., and estimate a 7-fold yearly increase in the global median prevalence between 2020 and 2022. Second, we estimate that vaccines against COVID-19 decrease the prevalence of long COVID among U.S. adults by 20.9% (95% CI: -32.0%, -9.9%) and, from the analysis of 158 countries, by -15.7% (95% CI: -18.0%, -13.4%) among all who had COVID-19. Our population-level analysis complements the current knowledge from patients data and highlights how aggregated data from fully operational epidemic surveillance and monitoring can inform about the potential impact of long COVID on national and global public health in the next future.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Manlio De Domenico. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Domenico</LastName><ForeName>Manlio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5158-8594</Identifier><AffiliationInfo><Affiliation>Department of Physics and Astronomy "Galileo Galilei", University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padua Center for Network Medicine, Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Glob Public Health</MedlineTA><NlmUniqueID>9918283779606676</NlmUniqueID><ISSNLinking>2767-3375</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37342998</ArticleId><ArticleId IdType="pmc">PMC10284420</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0001917</ArticleId><ArticleId IdType="pii">PGPH-D-22-01905</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization et al. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. In: A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021; 2021.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ (Clinical Research ed). 2021;374:n1648&#x2013;n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al.. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al.. Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al.. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nature Communications. 2022;13(1):1&#x2013;6. doi: 10.1038/s41467-022-29513-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch L, Zoller T, et al.. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature Communications. 2022;13(1):1&#x2013;13. doi: 10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al.. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nature communications. 2022;13(1):1&#x2013;10. doi: 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>of Disease Long COVID Collaborators GB. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604&#x2013;1615. doi: 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al.. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ (Clinical research ed). 2021;372:n693&#x2013;n693. doi: 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al.. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature communications. 2022;13(1):1&#x2013;11. doi: 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JC, Muecksch F, Finkin S, Tokuyama M, et al.. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644. doi: 10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al.. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y). 2022;3(6):371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127. doi: 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nature medicine. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine. 2022; p. 1&#x2013;9. doi: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al.. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022. doi: 10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023; p. 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. The Lancet Respiratory Medicine. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, et al.. Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nature Medicine. 2022; p. 1&#x2013;11. doi: 10.1038/s41591-022-02107-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02107-4</ArticleId><ArticleId IdType="pmc">PMC9873574</ArticleId><ArticleId IdType="pubmed">36482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, et al.. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nature Medicine. 2022; p. 1&#x2013;10. doi: 10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature medicine. 2022;28(11):2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nature medicine. 2022;28(11):2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et al.. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nature Medicine. 2022;28(10):2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al.. Post-acute COVID-19 syndrome. European Respiratory Review. 2022;31(163). doi: 10.1183/16000617.0185-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, O&#x2019;Mahoney L, Ayoubkhani D, Banerjee A, Brightling C, Calvert M, et al.. Understanding and tracking the impact of long COVID in the United Kingdom. Nature medicine. 2022;28(1):11&#x2013;15. doi: 10.1038/s41591-021-01591-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01591-4</ArticleId><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al.. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53(101624):101624. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al.. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. bmj. 2022;377. doi: 10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al.. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676&#x2013;678. doi: 10.1001/jama.2022.11691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nature Medicine. 2022;28(5):911&#x2013;923. doi: 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs JD, Karim SSA, Aknin L, Allen J, Brosb&#xf8;l K, Colombo F, et al.. The Lancet Commission on lessons for the future from the COVID-19 pandemic. The Lancet. 2022;400(10359):1224&#x2013;1280. doi: 10.1016/S0140-6736(22)01585-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01585-9</ArticleId><ArticleId IdType="pmc">PMC9539542</ArticleId><ArticleId IdType="pubmed">36115368</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK; 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk.</Citation></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 August 2022; 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4august2022.</Citation></Reference><Reference><Citation>Long COVID&#x2014;Household Pulse Survey&#x2014;COVID-19&#x2014;cdc.gov;. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference><Reference><Citation>GitHub&#x2014;CSSEGISandData/COVID-19: Novel Coronavirus (COVID-19) Cases, provided by JHU CSSE&#x2014;github.com;. https://github.com/CSSEGISandData/COVID-19.</Citation></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Daily new estimated COVID-19 infections from the IHME model&#x2014;ourworldindata.org;. https://ourworldindata.org/grapher/daily-new-estimated-covid-19-infections-ihme-model.</Citation></Reference><Reference><Citation>Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, et al.. A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022;611(7935):332&#x2013;345. doi: 10.1038/s41586-022-05398-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05398-2</ArticleId><ArticleId IdType="pmc">PMC9646517</ArticleId><ArticleId IdType="pubmed">36329272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, et al.. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020&#x2013;21. The Lancet. 2022;399(10334):1513&#x2013;1536. doi: 10.1016/S0140-6736(21)02796-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson SW, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al.. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022;. doi: 10.1101/2022.05.26.22275532</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId><ArticleId IdType="pmc">PMC9164454</ArticleId><ArticleId IdType="pubmed">35664995</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Vaccinations in the United States&#x2014;cdc.gov;. https://covid.cdc.gov/covid-data-tracker/#vaccinations.</Citation></Reference><Reference><Citation>Coronavirus (COVID-19) Vaccinations&#x2014;ourworldindata.org;. https://ourworldindata.org/covid-vaccinations.</Citation></Reference><Reference><Citation>World Population Prospects&#x2014;Population Division&#x2014;United Nations&#x2014;population.un.org;. https://population.un.org/wpp/.</Citation></Reference><Reference><Citation>Bureau UC. Census.gov&#x2014;census.gov;. https://www.census.gov/.</Citation></Reference><Reference><Citation>Gastner MT, Newman ME. Diffusion-based method for producing density-equalizing maps. Proceedings of the National Academy of Sciences. 2004;101(20):7499&#x2013;7504. doi: 10.1073/pnas.0400280101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0400280101</ArticleId><ArticleId IdType="pmc">PMC419634</ArticleId><ArticleId IdType="pubmed">15136719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Infectious Diseases. COVID-19 vaccine equity and booster doses. Lancet Infect Dis. 2021;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00486-2</ArticleId><ArticleId IdType="pmc">PMC8360703</ArticleId><ArticleId IdType="pubmed">34391506</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre PB, Aggarwal R, Jani I, Jawad J, Kochhar S, MacDonald N, et al.. COVID-19 vaccine strategies must focus on severe disease and global equity. The Lancet. 2022;399(10322):406&#x2013;410. doi: 10.1016/S0140-6736(21)02835-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02835-X</ArticleId><ArticleId IdType="pmc">PMC8676417</ArticleId><ArticleId IdType="pubmed">34922639</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco PL. The vaccine equity crisis is a stress test for all future major environmental challenges. Science of The Total Environment. 2022;825:154073. doi: 10.1016/j.scitotenv.2022.154073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2022.154073</ArticleId><ArticleId IdType="pubmed">35202684</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, et al.. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet Infectious Diseases. 2020;20(7):793&#x2013;802. doi: 10.1016/S1473-3099(20)30230-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30230-9</ArticleId><ArticleId IdType="pmc">PMC7269887</ArticleId><ArticleId IdType="pubmed">32247326</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JT, Chinazzi M, Perra N, Mu K, y Piontti AP, Ajelli M, et al.. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature. 2021. doi: 10.1038/s41586-021-04130-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04130-w</ArticleId><ArticleId IdType="pmc">PMC8636257</ArticleId><ArticleId IdType="pubmed">34695837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al.. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395&#x2013;400. doi: 10.1126/science.aba9757</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba9757</ArticleId><ArticleId IdType="pmc">PMC7164386</ArticleId><ArticleId IdType="pubmed">32144116</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehning J, Zierenberg J, Spitzner FP, Wibral M, Neto JP, Wilczek M, et al.. Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions. Science. 2020;369 (6500). doi: 10.1126/science.abb9789</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9789</ArticleId><ArticleId IdType="pmc">PMC7239331</ArticleId><ArticleId IdType="pubmed">32414780</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier BF, Brockmann D. Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Science. 2020;368(6492):742&#x2013;746. doi: 10.1126/science.abb4557</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4557</ArticleId><ArticleId IdType="pmc">PMC7164388</ArticleId><ArticleId IdType="pubmed">32269067</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas A, Cota W, G&#xf3;mez-Garde&#xf1;es J, G&#xf3;mez S, Granell C, Matamalas JT, et al.. Modeling the spatiotemporal epidemic spreading of COVID-19 and the impact of mobility and social distancing interventions. Physical Review X. 2020;10(4):041055. doi: 10.1103/PhysRevX.10.041055</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevX.10.041055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer MUG, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone JT, et al.. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science. 2021;373(6557):889&#x2013;895. doi: 10.1126/science.abj0113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj0113</ArticleId><ArticleId IdType="pmc">PMC9269003</ArticleId><ArticleId IdType="pubmed">34301854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al.. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371 (6526). doi: 10.1126/science.abe2424</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe2424</ArticleId><ArticleId IdType="pmc">PMC7857413</ArticleId><ArticleId IdType="pubmed">33234698</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenico LD, Sabbatini CE, Bo&#xeb;lle PY, Poletto C, Cr&#xe9;pey P, Paireau J, et al.. Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic. Communications Medicine. 2021;1(1). doi: 10.1038/s43856-021-00057-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00057-5</ArticleId><ArticleId IdType="pmc">PMC9053235</ArticleId><ArticleId IdType="pubmed">35602184</ArticleId></ArticleIdList></Reference><Reference><Citation>Marziano V, Guzzetta G, Mammone A, Riccardo F, Poletti P, Trentini F, et al.. The effect of COVID-19 vaccination in Italy and perspectives for living with the virus. Nature Communications. 2021;12(1):1&#x2013;8. doi: 10.1038/s41467-021-27532-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27532-w</ArticleId><ArticleId IdType="pmc">PMC8671442</ArticleId><ArticleId IdType="pubmed">34907206</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouvellet P, Bhatia S, Cori A, Ainslie KE, Baguelin M, Bhatt S, et al.. Reduction in mobility and COVID-19 transmission. Nature communications. 2021;12(1):1&#x2013;9. doi: 10.1038/s41467-021-21358-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21358-2</ArticleId><ArticleId IdType="pmc">PMC7889876</ArticleId><ArticleId IdType="pubmed">33597546</ArticleId></ArticleIdList></Reference><Reference><Citation>Cramer EY, Ray EL, Lopez VK, Bracher J, Brennen A, Castro Rivadeneira AJ, et al.. Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States. Proceedings of the National Academy of Sciences. 2022;119(15):e2113561119. doi: 10.1073/pnas.2113561119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113561119</ArticleId><ArticleId IdType="pmc">PMC9169655</ArticleId><ArticleId IdType="pubmed">35394862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco PL, Valle F, De Domenico M. Proactive vs. reactive country responses to the COVID19 pandemic shock. PLOS Global Public Health, In press. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10021818</ArticleId><ArticleId IdType="pubmed">36962977</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell D, Lindsley WG, Brooks JT. Reducing SARS-CoV-2 in Shared Indoor Air. JAMA. 2022;328(2):141&#x2013;142. doi: 10.1001/jama.2022.9970</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.9970</ArticleId><ArticleId IdType="pmc">PMC11338317</ArticleId><ArticleId IdType="pubmed">35671318</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonanno G, Ricolfi L, Morawska L, Stabile L. Increasing ventilation reduces SARS-CoV-2 airborne transmission in schools: A retrospective cohort study in Italy&#x2019;s Marche region. Frontiers in Public Health. 2022;10:4922. doi: 10.3389/fpubh.2022.1087087</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1087087</ArticleId><ArticleId IdType="pmc">PMC9787545</ArticleId><ArticleId IdType="pubmed">36568748</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JG, Ibrahim AM. Indoor air changes and potential implications for SARS-CoV-2 transmission. Jama. 2021;325(20):2112&#x2013;2113. doi: 10.1001/jama.2021.5053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5053</ArticleId><ArticleId IdType="pubmed">33861316</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikrishna D, Karan A, Dhillon RS. SARS-CoV-2 Reduction in Shared Indoor Air. JAMA. 2022;328(21):2162&#x2013;2163. doi: 10.1001/jama.2022.18028</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18028</ArticleId><ArticleId IdType="pubmed">36472600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarocostas J. How to fight an infodemic. The lancet. 2020;395(10225):676. doi: 10.1016/S0140-6736(20)30461-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30461-X</ArticleId><ArticleId IdType="pmc">PMC7133615</ArticleId><ArticleId IdType="pubmed">32113495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, D&#x2019;Agostino M, Garcia-Saiso S, et al.. Framework for managing the COVID-19 infodemic: methods and results of an online, crowdsourced WHO technical consultation. Journal of medical Internet research. 2020;22(6):e19659. doi: 10.2196/19659</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19659</ArticleId><ArticleId IdType="pmc">PMC7332158</ArticleId><ArticleId IdType="pubmed">32558655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallotti R, Valle F, Castaldo N, Sacco P, De Domenico M. Assessing the risks of &#x2018;infodemics&#x2019; in response to COVID-19 epidemics. Nature human behaviour. 2020;4(12):1285&#x2013;1293. doi: 10.1038/s41562-020-00994-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-020-00994-6</ArticleId><ArticleId IdType="pubmed">33122812</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden S. Misinformation: susceptibility, spread, and interventions to immunize the public. Nature Medicine. 2022;28(3):460&#x2013;467. doi: 10.1038/s41591-022-01713-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01713-6</ArticleId><ArticleId IdType="pubmed">35273402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A, Abdalla SM, Chattu VK, Erondu NA, Lee TL, Singh S, et al.. Pandemic preparedness and response: exploring the role of universal health coverage within the global health security architecture. Lancet Glob Health. 2022; p. e1675&#x2013;e1683. doi: 10.1016/S2214-109X(22)00341-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00341-2</ArticleId><ArticleId IdType="pmc">PMC9514836</ArticleId><ArticleId IdType="pubmed">36179734</ArticleId></ArticleIdList></Reference><Reference><Citation>Klamser P, d&#x2019;Andrea V, Di Lauro F, Zachariae A, Bontorin S, di Nardo A, et al.. Enhancing global preparedness during an ongoing pandemic from partial and noisy data. medRxiv. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10282504</ArticleId><ArticleId IdType="pubmed">37351112</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, et al.. Climate change increases cross-species viral transmission risk. Nature. 2022; p. 1&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">35483403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>